O	O	O	0	10	Regulation	Regulation	B-NP	NN	O	0	ROOT	O
O	O	O	11	13	of	of	B-PP	IN	O	1	NMOD	O
T1	B-Protein	B-Protein	14	16	GM	GM	B-NP	NNP	O	7	NMOD	O
T1	I-Protein	I-Protein	16	17	-	-	I-NP	HYPH	O	7	NMOD	O
T1	I-Protein	I-Protein	17	20	CSF	CSF	I-NP	NN	B-DNA	7	NMOD	B-DNA
O	O	O	21	25	gene	gene	I-NP	NN	I-DNA	7	NMOD	I-DNA
O	O	O	26	39	transcription	transcription	I-NP	NN	O	2	PMOD	O
O	O	O	40	42	by	by	B-PP	IN	O	1	NMOD	O
T13	B-Entity	B-Entity	43	47	core	core	B-NP	NN	B-protein	12	NMOD	B-protein
T13	I-Entity	I-Entity	47	48	-	-	O	HYPH	I-protein	12	NMOD	I-protein
T13	I-Entity	I-Entity	48	55	binding	bind	B-NP	VBG	I-protein	12	NMOD	I-protein
T13	I-Entity	I-Entity	56	62	factor	factor	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	62	63	.	.	O	.	O	1	P	O

T2	B-Protein	B-Protein	65	67	GM	GM	B-NP	NNP	O	5	NMOD	O
T2	I-Protein	I-Protein	67	68	-	-	I-NP	HYPH	O	5	NMOD	O
T2	I-Protein	I-Protein	68	71	CSF	CSF	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	O	72	76	gene	gene	I-NP	NN	I-DNA	5	NMOD	I-DNA
O	O	O	77	87	activation	activation	I-NP	NN	O	9	SUB	O
O	O	O	88	90	in	in	B-PP	IN	O	5	NMOD	O
O	O	O	91	92	T	T	B-NP	NN	B-cell_type	8	NMOD	B-cell_type
O	O	O	93	98	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	I-cell_type
O	O	O	99	101	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	102	107	known	know	I-VP	VBN	O	9	VC	O
O	O	O	108	110	to	to	I-VP	TO	O	12	VMOD	O
O	O	O	111	118	involve	involve	I-VP	VB	O	10	VMOD	O
O	O	O	119	122	the	the	B-NP	DT	O	15	NMOD	O
O	O	O	123	136	transcription	transcription	I-NP	NN	B-protein	15	NMOD	B-protein
O	O	O	137	144	factors	factor	I-NP	NNS	I-protein	29	NMOD	I-protein
T14	B-Entity	B-Entity	145	152	nuclear	nuclear	B-NP	JJ	B-protein	20	NMOD	B-protein
T14	I-Entity	I-Entity	153	159	factor	factor	I-NP	NN	I-protein	20	NMOD	I-protein
T14	I-Entity	I-Entity	159	160	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
T14	I-Entity	I-Entity	160	165	kappa	kappa	I-NP	NN	I-protein	20	NMOD	I-protein
T14	I-Entity	I-Entity	166	167	B	B	I-NP	NN	I-protein	23	NMOD	I-protein
O	O	O	167	168	,	,	O	,	O	23	P	O
T15	B-Entity	B-Entity	169	171	AP	AP	B-NP	NN	B-protein	23	NMOD	B-protein
T15	I-Entity	I-Entity	171	172	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T15	I-Entity	I-Entity	172	173	1	1	I-NP	CD	I-protein	23	NMOD	I-protein
O	O	O	173	174	,	,	O	,	O	23	P	O
O	O	O	175	179	NFAT	NFAT	B-NP	NN	B-protein	29	NMOD	B-protein
O	O	O	179	180	,	,	O	,	O	29	P	O
O	O	O	181	184	and	and	O	CC	O	29	NMOD	O
T3	B-Protein	B-Protein	185	188	Sp1	Sp1	B-NP	NN	B-protein	12	OBJ	B-protein
O	O	O	188	189	.	.	O	.	O	9	P	O

O	O	O	190	194	Here	Here	B-ADVP	RB	O	3	VMOD	O
O	O	O	195	197	we	we	B-NP	PRP	O	3	SUB	O
O	O	O	198	209	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	210	214	that	that	B-SBAR	IN	O	3	VMOD	O
O	O	O	215	218	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	219	224	human	human	I-NP	JJ	B-DNA	10	NMOD	B-DNA
T4	B-Protein	B-Protein	225	227	GM	GM	I-NP	NNP	I-DNA	10	NMOD	I-DNA
T4	I-Protein	I-Protein	227	228	-	-	I-NP	HYPH	I-DNA	10	NMOD	I-DNA
T4	I-Protein	I-Protein	228	231	CSF	CSF	I-NP	NN	I-DNA	10	NMOD	I-DNA
T16	B-Entity	B-Entity	232	240	promoter	promoter	I-NP	NN	I-DNA	12	NMOD	I-DNA
O	O	O	241	244	and	and	I-NP	CC	O	12	NMOD	O
T17	B-Entity	B-Entity	245	253	enhancer	enhancer	I-NP	NN	B-DNA	14	SUB	B-DNA
O	O	O	254	258	also	also	B-ADVP	RB	O	14	VMOD	O
O	O	O	259	268	encompass	encompass	B-VP	VBP	O	4	SBAR	O
O	O	O	269	276	binding	bind	B-NP	VBG	B-DNA	16	NMOD	B-DNA
O	O	O	277	282	sites	site	I-NP	NNS	I-DNA	14	OBJ	I-DNA
O	O	O	283	286	for	for	B-PP	IN	O	16	NMOD	O
T18	B-Entity	B-Entity	287	291	core	core	B-NP	NN	B-protein	21	NMOD	B-protein
T18	I-Entity	I-Entity	291	292	-	-	O	HYPH	I-protein	21	NMOD	I-protein
T18	I-Entity	I-Entity	292	299	binding	bind	B-VP	VBG	I-protein	21	NMOD	I-protein
T18	I-Entity	I-Entity	300	306	factor	factor	B-NP	NN	I-protein	17	PMOD	I-protein
O	O	O	307	308	(	(	O	(	O	24	DEP	O
T19	B-Entity	B-Entity	308	311	CBF	CBF	B-NP	NN	B-protein	24	DEP	B-protein
O	O	O	311	312	)	)	O	)	O	21	NMOD	O
O	O	O	312	313	.	.	O	.	O	3	P	O

O	O	O	314	327	Significantly	Significantly	B-ADVP	RB	O	6	VMOD	O
O	O	O	327	328	,	,	O	,	O	6	P	O
O	O	O	329	332	the	the	B-NP	DT	O	5	NMOD	O
T20,T21	B-Entity,B-Entity	B-Entity,B-Entity	333	336	CBF	CBF	I-NP	NN	B-DNA	5	NMOD	B-DNA
T20	I-Entity	I-Entity	337	342	sites	site	I-NP	NNS	I-DNA	6	SUB	I-DNA
O	O	O	343	346	are	be	B-VP	VBP	O	0	ROOT	O
O	O	O	347	349	in	in	B-PP	IN	O	6	VMOD	O
O	O	O	350	354	each	each	B-NP	DT	O	9	NMOD	O
O	O	O	355	359	case	case	I-NP	NN	O	7	PMOD	O
O	O	O	360	369	contained	contain	B-VP	VBN	O	6	VC	O
O	O	O	370	376	within	within	B-PP	IN	O	10	VMOD	O
O	O	O	377	380	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	381	388	minimum	minimum	I-NP	JJ	O	16	NMOD	O
T22	B-Entity	B-Entity	389	398	essential	essential	I-NP	JJ	B-DNA	16	NMOD	B-DNA
T22	I-Entity	I-Entity	399	403	core	core	I-NP	NN	I-DNA	16	NMOD	I-DNA
T22	I-Entity	I-Entity	404	411	regions	region	I-NP	NNS	I-DNA	11	PMOD	I-DNA
O	O	O	412	420	required	require	B-VP	VBN	O	16	NMOD	O
O	O	O	421	424	for	for	B-PP	IN	O	17	VMOD	O
O	O	O	425	434	inducible	inducible	B-NP	JJ	O	20	NMOD	O
O	O	O	435	445	activation	activation	I-NP	NN	O	18	PMOD	O
O	O	O	446	448	of	of	B-PP	IN	O	20	NMOD	O
O	O	O	449	462	transcription	transcription	B-NP	NN	O	21	PMOD	O
O	O	O	462	463	.	.	O	.	O	6	P	O

O	O	O	464	475	Furthermore	Furthermore	B-ADVP	RB	O	12	VMOD	O
O	O	O	475	476	,	,	O	,	O	12	P	O
O	O	O	477	482	these	these	B-NP	DT	O	5	NMOD	O
O	O	O	483	487	core	core	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	O	488	495	regions	region	I-NP	NNS	I-DNA	12	SUB	I-DNA
O	O	O	496	498	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	499	502	the	the	B-NP	DT	O	10	NMOD	O
O	O	O	503	511	enhancer	enhancer	I-NP	NN	B-DNA	10	NMOD	B-DNA
O	O	O	512	515	and	and	I-NP	CC	O	10	NMOD	O
O	O	O	516	524	promoter	promoter	I-NP	NN	O	11	NMOD	O
O	O	O	525	529	each	each	B-NP	DT	O	6	PMOD	O
O	O	O	530	539	encompass	encompass	B-VP	VBP	O	0	ROOT	O
T23	B-Entity	B-Entity	540	547	closely	closely	I-VP	RB	B-DNA	14	AMOD	B-DNA
T23	I-Entity	I-Entity	548	554	linked	link	I-VP	VBN	I-DNA	16	NMOD	I-DNA
T23	I-Entity	I-Entity	555	562	binding	bind	B-NP	VBG	I-DNA	16	NMOD	I-DNA
T23	I-Entity	I-Entity	563	568	sites	site	I-NP	NNS	I-DNA	12	OBJ	I-DNA
O	O	O	569	572	for	for	B-PP	IN	O	16	NMOD	O
T24	B-Entity	B-Entity	573	576	CBF	CBF	B-NP	NN	B-protein	25	NMOD	B-protein
O	O	O	576	577	,	,	O	,	O	25	P	O
T25	B-Entity	B-Entity	578	580	AP	AP	B-NP	NN	B-protein	21	NMOD	B-protein
T25	I-Entity	I-Entity	580	581	-	-	B-NP	HYPH	I-protein	25	NMOD	I-protein
T25	I-Entity	I-Entity	581	582	1	1	I-NP	CD	I-protein	21	NMOD	I-protein
O	O	O	582	583	,	,	O	,	O	25	P	O
O	O	O	584	587	and	and	O	CC	O	25	NMOD	O
T5	B-Protein	B-Protein	588	593	NFATp	NFATp	B-NP	NN	B-protein	17	PMOD	B-protein
O	O	O	593	594	.	.	O	.	O	12	P	O

O	O	O	595	598	The	The	B-NP	DT	O	8	NMOD	O
T6,T26	B-Protein,B-Entity	B-Protein,B-Entity	599	601	GM	GM	I-NP	NNP	O	8	NMOD	O
T6,T26	I-Protein,I-Entity	I-Protein,I-Entity	601	602	-	-	I-NP	HYPH	O	8	NMOD	O
T6,T26	I-Protein,I-Entity	I-Protein,I-Entity	602	605	CSF	CSF	I-NP	NN	B-DNA	8	NMOD	B-DNA
T26	I-Entity	I-Entity	606	614	promoter	promoter	I-NP	NN	I-DNA	8	NMOD	I-DNA
T26,T27	I-Entity,B-Entity	I-Entity,B-Entity	615	618	CBF	CBF	I-NP	NN	O	8	NMOD	O
T26	I-Entity	I-Entity	619	623	site	site	I-NP	NN	O	8	NMOD	O
T28	I-Entity	I-Entity	624	632	TGTGGTCA	TGTGGTCA	I-NP	NN	O	9	SUB	O
O	O	O	633	635	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	636	643	located	located	B-NP	JJ	O	9	PRD	O
T29	B-Entity	B-Entity	644	646	51	51	I-NP	CD	B-DNA	12	NMOD	B-DNA
T29	I-Entity	I-Entity	647	649	bp	bp	I-NP	NN	I-DNA	13	AMOD	I-DNA
T29	I-Entity	I-Entity	650	658	upstream	upstream	B-ADVP	RB	I-DNA	21	VMOD	I-DNA
O	O	O	659	661	of	of	B-PP	IN	O	13	AMOD	O
O	O	O	662	665	the	the	B-NP	DT	O	18	NMOD	O
T30	B-Entity	B-Entity	666	679	transcription	transcription	I-NP	NN	B-DNA	18	NMOD	B-DNA
T30	I-Entity	I-Entity	680	685	start	start	I-NP	NN	I-DNA	18	NMOD	I-DNA
T30	I-Entity	I-Entity	686	690	site	site	I-NP	NN	I-DNA	14	PMOD	I-DNA
O	O	O	691	694	and	and	O	CC	O	13	AMOD	O
O	O	O	695	699	also	also	B-VP	RB	O	21	VMOD	O
O	O	O	700	708	overlaps	overlap	I-VP	VBZ	O	10	AMOD	O
O	O	O	709	710	a	a	B-NP	DT	O	27	NMOD	O
T7	B-Protein	B-Protein	711	713	YY	YY	I-NP	NN	B-DNA	27	NMOD	B-DNA
T7	I-Protein	I-Protein	713	714	-	-	B-NP	HYPH	I-DNA	27	NMOD	I-DNA
T7	I-Protein	I-Protein	714	715	1	1	I-NP	CD	I-DNA	27	NMOD	I-DNA
T31	B-Entity	B-Entity	716	723	binding	binding	I-NP	NN	I-DNA	27	NMOD	I-DNA
T31	I-Entity	I-Entity	724	728	site	site	I-NP	NN	I-DNA	21	OBJ	I-DNA
O	O	O	728	729	.	.	O	.	O	9	P	O

O	O	O	730	731	A	A	B-NP	DT	O	5	NMOD	O
T32	B-Entity	B-Entity	732	733	2	2	I-NP	CD	O	5	NMOD	O
T32	I-Entity	I-Entity	733	734	-	-	I-NP	HYPH	O	5	NMOD	O
T32	I-Entity	I-Entity	734	736	bp	bp	I-NP	NN	O	5	NMOD	O
T32	I-Entity	I-Entity	737	745	mutation	mutation	I-NP	NN	O	10	SUB	O
O	O	O	746	752	within	within	B-PP	IN	O	5	NMOD	O
O	O	O	753	756	the	the	B-NP	DT	O	9	NMOD	O
T33,T34	B-Entity,B-Entity	B-Entity,B-Entity	757	760	CBF	CBF	I-NP	NN	B-DNA	9	NMOD	B-DNA
T33	I-Entity	I-Entity	761	765	site	site	I-NP	NN	I-DNA	6	PMOD	I-DNA
O	O	O	766	774	resulted	result	B-VP	VBD	O	0	ROOT	O
O	O	O	775	777	in	in	B-PP	IN	O	10	VMOD	O
O	O	O	778	779	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	780	781	2	2	I-NP	CD	O	15	AMOD	O
O	O	O	781	782	-	-	I-NP	HYPH	O	15	P	O
O	O	O	782	783	3	3	I-NP	CD	O	17	AMOD	O
O	O	O	783	784	-	-	I-NP	HYPH	O	17	AMOD	O
O	O	O	784	788	fold	fold	I-NP	JJ	O	18	NMOD	O
O	O	O	789	797	decrease	decrease	I-NP	NN	O	11	PMOD	O
O	O	O	798	800	in	in	B-PP	IN	O	18	NMOD	O
O	O	O	801	804	the	the	B-NP	DT	O	21	NMOD	O
O	O	O	805	815	activities	activity	I-NP	NNS	O	19	PMOD	O
O	O	O	816	818	of	of	B-PP	IN	O	21	NMOD	O
O	O	O	819	823	both	both	O	CC	O	40	NMOD	O
O	O	O	824	825	a	a	B-NP	DT	O	30	NMOD	O
O	O	O	826	828	69	69	I-NP	CD	B-DNA	30	NMOD	B-DNA
O	O	O	828	829	-	-	I-NP	HYPH	I-DNA	30	NMOD	I-DNA
O	O	O	829	831	bp	bp	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	832	840	proximal	proximal	I-NP	JJ	I-DNA	30	NMOD	I-DNA
O	O	O	841	849	promoter	promoter	I-NP	NN	I-DNA	30	NMOD	I-DNA
O	O	O	850	858	fragment	fragment	I-NP	NN	I-DNA	40	NMOD	I-DNA
O	O	O	859	862	and	and	O	CC	O	40	NMOD	O
O	O	O	863	864	a	a	B-NP	DT	O	40	NMOD	O
O	O	O	865	868	627	627	I-NP	CD	B-DNA	40	NMOD	B-DNA
O	O	O	868	869	-	-	I-NP	HYPH	I-DNA	40	NMOD	I-DNA
O	O	O	869	871	bp	bp	I-NP	NN	I-DNA	40	NMOD	I-DNA
O	O	O	872	876	full	full	I-NP	JJ	I-DNA	40	NMOD	I-DNA
O	O	O	876	877	-	-	I-NP	HYPH	I-DNA	40	NMOD	I-DNA
O	O	O	877	883	length	length	I-NP	NN	I-DNA	40	NMOD	I-DNA
O	O	O	884	892	promoter	promoter	I-NP	NN	I-DNA	40	NMOD	I-DNA
O	O	O	893	901	fragment	fragment	I-NP	NN	I-DNA	22	PMOD	I-DNA
O	O	O	901	902	.	.	O	.	O	10	P	O

O	O	O	903	911	Stepwise	Stepwise	B-NP	JJ	O	2	NMOD	O
O	O	O	912	921	deletions	deletion	I-NP	NNS	O	8	SUB	O
O	O	O	922	926	into	into	B-PP	IN	O	2	NMOD	O
O	O	O	927	930	the	the	B-NP	DT	O	6	NMOD	O
T35	B-Entity	B-Entity	931	939	proximal	proximal	I-NP	JJ	B-DNA	6	NMOD	B-DNA
T35	I-Entity	I-Entity	940	948	promoter	promoter	I-NP	NN	I-DNA	3	PMOD	I-DNA
O	O	O	949	953	also	also	B-ADVP	RB	O	8	VMOD	O
O	O	O	954	962	revealed	reveal	B-VP	VBD	O	0	ROOT	O
O	O	O	963	967	that	that	B-SBAR	IN	O	8	VMOD	O
O	O	O	968	971	the	the	B-NP	DT	O	12	NMOD	O
T36,T37	B-Entity,B-Entity	B-Entity,B-Entity	972	975	CBF	CBF	I-NP	NN	B-DNA	12	NMOD	B-DNA
T36	I-Entity	I-Entity	976	980	site	site	I-NP	NN	I-DNA	20	NMOD	I-DNA
O	O	O	980	981	,	,	O	,	O	20	P	O
O	O	O	982	985	but	but	B-CONJP	CC	O	20	NMOD	O
O	O	O	986	989	not	not	I-CONJP	RB	O	14	DEP	O
O	O	O	990	993	the	the	B-NP	DT	O	20	NMOD	O
T8	B-Protein	B-Protein	994	996	YY	YY	I-NP	NN	B-DNA	20	NMOD	B-DNA
T8	I-Protein	I-Protein	996	997	-	-	B-NP	HYPH	I-DNA	20	NMOD	I-DNA
T8	I-Protein	I-Protein	997	998	1	1	I-NP	CD	I-DNA	20	NMOD	I-DNA
T38	B-Entity	B-Entity	999	1003	site	site	I-NP	NN	I-DNA	22	SUB	I-DNA
O	O	O	1003	1004	,	,	O	,	O	20	P	O
O	O	O	1005	1008	was	be	B-VP	VBD	O	9	SBAR	O
O	O	O	1009	1017	required	require	I-VP	VBN	O	22	VC	O
O	O	O	1018	1021	for	for	B-PP	IN	O	23	VMOD	O
O	O	O	1022	1031	efficient	efficient	B-NP	JJ	O	26	NMOD	O
O	O	O	1032	1041	induction	induction	I-NP	NN	O	24	PMOD	O
O	O	O	1042	1044	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	1045	1060	transcriptional	transcriptional	B-NP	JJ	O	29	NMOD	O
O	O	O	1061	1071	activation	activation	I-NP	NN	O	27	PMOD	O
O	O	O	1071	1072	.	.	O	.	O	8	P	O

O	O	O	1073	1076	The	The	B-NP	DT	O	6	NMOD	O
T9	B-Protein	B-Protein	1077	1081	AML1	AML1	I-NP	NN	B-DNA	5	NMOD	B-DNA
O	O	O	1082	1085	and	and	O	CC	I-DNA	5	NMOD	I-DNA
T10	B-Protein	B-Protein	1086	1089	CBF	CBF	B-NP	NN	I-DNA	5	NMOD	I-DNA
T10	I-Protein	I-Protein	1090	1094	beta	beta	I-NP	NN	I-DNA	6	NMOD	I-DNA
O	O	O	1095	1100	genes	gene	I-NP	NNS	I-DNA	10	NMOD	I-DNA
O	O	O	1101	1105	that	that	B-NP	WDT	O	10	NMOD	O
O	O	O	1106	1112	encode	encode	B-VP	VBP	O	7	SBAR	O
T39	B-Entity	B-Entity	1113	1116	CBF	CBF	B-NP	NN	B-protein	8	OBJ	B-protein
O	O	O	1117	1121	each	each	B-NP	DT	O	11	SUB	O
O	O	O	1122	1126	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	1127	1130	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1131	1138	ability	ability	I-NP	NN	O	11	OBJ	O
O	O	O	1139	1141	to	to	B-VP	TO	O	15	VMOD	O
O	O	O	1142	1151	influence	influence	I-VP	VB	O	13	NMOD	O
O	O	O	1152	1156	cell	cell	B-NP	NN	O	19	NMOD	O
O	O	O	1157	1163	growth	growth	B-NP	NN	O	19	NMOD	O
O	O	O	1164	1167	and	and	O	CC	O	19	NMOD	O
O	O	O	1168	1183	differentiation	differentiation	B-NP	NN	O	15	OBJ	O
O	O	O	1184	1187	and	and	O	CC	O	11	VMOD	O
O	O	O	1188	1192	have	have	B-VP	VBP	O	11	VMOD	O
O	O	O	1193	1197	been	be	I-VP	VBN	O	21	VC	O
O	O	O	1198	1208	implicated	implicate	I-VP	VBN	O	22	VC	O
O	O	O	1209	1211	as	as	B-PP	IN	O	23	VMOD	O
T40	B-Entity	B-Entity	1212	1217	proto	proto	B-NP	AFX	B-DNA	27	NMOD	B-DNA
T40	I-Entity	I-Entity	1217	1218	-	-	I-NP	HYPH	I-DNA	27	NMOD	I-DNA
T40	I-Entity	I-Entity	1218	1227	oncogenes	oncogene	I-NP	NNS	I-DNA	24	PMOD	I-DNA
O	O	O	1228	1230	in	in	B-PP	IN	O	23	VMOD	O
O	O	O	1231	1236	acute	acute	B-NP	JJ	O	31	NMOD	O
O	O	O	1237	1244	myeloid	myeloid	I-NP	JJ	O	31	NMOD	O
O	O	O	1245	1253	leukemia	leukemia	I-NP	NN	O	28	PMOD	O
O	O	O	1253	1254	.	.	O	.	O	11	P	O

O	O	O	1255	1259	This	This	B-NP	DT	O	2	NMOD	O
O	O	O	1260	1265	study	study	I-NP	NN	O	3	SUB	O
O	O	O	1266	1270	adds	add	B-VP	VBZ	O	0	ROOT	O
T11	B-Protein	B-Protein	1271	1273	GM	GM	B-NP	NNP	O	3	OBJ	O
T11	I-Protein	I-Protein	1273	1274	-	-	I-NP	HYPH	O	4	NMOD	O
T11	I-Protein	I-Protein	1274	1277	CSF	CSF	I-NP	NN	B-protein	5	OBJ	B-protein
O	O	O	1278	1280	to	to	B-PP	TO	O	5	VMOD	O
O	O	O	1281	1282	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	1283	1290	growing	grow	I-NP	VBG	O	10	NMOD	O
O	O	O	1291	1295	list	list	I-NP	NN	O	7	PMOD	O
O	O	O	1296	1298	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	1299	1308	cytokines	cytokine	B-NP	NNS	B-protein	14	NMOD	B-protein
O	O	O	1309	1312	and	and	I-NP	CC	O	14	NMOD	O
O	O	O	1313	1322	receptors	receptor	I-NP	NNS	O	11	PMOD	O
O	O	O	1323	1327	that	that	B-NP	WDT	O	21	DEP	O
O	O	O	1328	1331	are	be	B-VP	VBP	O	15	SBAR	O
O	O	O	1332	1341	regulated	regulate	I-VP	VBN	O	16	VC	O
O	O	O	1342	1344	by	by	B-PP	IN	O	17	VMOD	O
T41	B-Entity	B-Entity	1345	1348	CBF	CBF	B-NP	NN	B-protein	18	PMOD	B-protein
O	O	O	1349	1352	and	and	O	CC	O	21	DEP	O
O	O	O	1353	1358	which	which	B-NP	WDT	O	14	NMOD	O
O	O	O	1359	1366	control	control	B-VP	VBP	O	21	SBAR	O
O	O	O	1367	1370	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	1371	1377	growth	growth	I-NP	NN	O	29	NMOD	O
O	O	O	1377	1378	,	,	O	,	O	29	P	O
O	O	O	1379	1394	differentiation	differentiation	B-NP	NN	O	29	NMOD	O
O	O	O	1394	1395	,	,	O	,	O	29	P	O
O	O	O	1396	1399	and	and	O	CC	O	29	NMOD	O
O	O	O	1400	1410	activation	activation	B-NP	NN	O	22	OBJ	O
O	O	O	1411	1413	of	of	B-PP	IN	O	29	NMOD	O
O	O	O	1414	1425	hemopoietic	hemopoietic	B-NP	JJ	B-cell_type	32	NMOD	B-cell_type
O	O	O	1426	1431	cells	cell	I-NP	NNS	I-cell_type	30	PMOD	I-cell_type
O	O	O	1431	1432	.	.	O	.	O	3	P	O

O	O	O	1433	1436	The	The	B-NP	DT	O	5	NMOD	O
T12	B-Protein	B-Protein	1437	1439	GM	GM	I-NP	NNP	O	5	NMOD	O
T12	I-Protein	I-Protein	1439	1440	-	-	I-NP	HYPH	O	5	NMOD	O
T12	I-Protein	I-Protein	1440	1443	CSF	CSF	I-NP	NN	B-DNA	5	NMOD	B-DNA
T42	B-Entity	B-Entity	1444	1449	locus	locus	I-NP	NN	I-DNA	6	SUB	I-DNA
O	O	O	1450	1453	may	may	B-VP	MD	O	0	ROOT	O
O	O	O	1454	1463	represent	represent	I-VP	VB	O	6	VC	O
O	O	O	1464	1467	one	one	B-NP	CD	O	7	OBJ	O
O	O	O	1468	1470	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	1471	1478	several	several	B-NP	JJ	O	12	NMOD	O
O	O	O	1479	1485	target	target	I-NP	NN	B-DNA	12	NMOD	B-DNA
O	O	O	1486	1491	genes	gene	I-NP	NNS	I-DNA	9	PMOD	I-DNA
O	O	O	1492	1496	that	that	B-NP	WDT	O	12	NMOD	O
O	O	O	1497	1500	are	be	B-VP	VBP	O	13	SBAR	O
O	O	O	1501	1513	dysregulated	dysregulate	I-VP	VBN	O	14	VC	O
O	O	O	1514	1516	in	in	B-PP	IN	O	15	VMOD	O
O	O	O	1517	1522	acute	acute	B-NP	JJ	O	19	NMOD	O
O	O	O	1523	1530	myeloid	myeloid	I-NP	JJ	O	19	NMOD	O
O	O	O	1531	1539	leukemia	leukemia	I-NP	NN	O	16	PMOD	O
O	O	O	1539	1540	.	.	O	.	O	6	P	O
